Thursday, September 6, 2012

Astex, U.K. groups form blood cancer research pact

Astex Pharmaceuticals Inc. inked a research collaboration with Cancer Research Technology Ltd. and the Institute of Cancer Research in London to discover and develop drug candidates for blood cancer caused by epigenetics. Dublin-based Astex (NASDAQ: ASTX) did not disclose the value of the deal or say how long the collaboration would last.

No comments:

Post a Comment